Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy

被引：0
|
作者：
Ghidini, M. [1 ]
Hahne, J. C. [2 ]
Senti, C. [3 ]
Tomasello, G. [1 ]
Ratti, M. [3 ]
Heide, T. [4 ]
Garrone, O. [1 ]
Cortellini, A. [5 ]
Passalacqua, R. [3 ]
Valeri, N. [5 ]
机构：
[1] Fdn IRCCS Osped Maggiore Policlin, Oncol Unit, Milan, Italy
[2] ICR, Ctr Mol Pathol, London, England
[3] ASST Cremona Azienda Sociosanitaria Terr, Oncol Unit, Cremona, Italy
[4] Human Technopole, Computat Biol Res Ctr, Milan, Italy
[5] Imperial Coll London, Dept Surg & Canc, London, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1355
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2326P
引用
收藏
页码：S1188 / S1188
页数：1
相关论文
共 50 条
  • [41] CAPECITABINE AND IRINOTECAN (CAPIRI) AS FIRST -LINE TREATMENT FOR PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Bounedjar, A.
    Smail, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 67 - 68
  • [42] A randomized study evaluating tailoring of advanced/metastatic colorectal cancer (mCRC) therapy using circulating tumor DNA (ctDNA): TACT-D
    Raghav, Kanwal Pratap Singh
    Xiao, Lianchun
    Lewis, Courtney
    Zeller, Brittany E.
    Overman, Michael J.
    Huey, Ryan W.
    Dasari, Arvind
    Chang, Kyle
    Quinn, Katie
    Shen, John Paul Y. C.
    Parseghian, Christine Megerdichian
    Willis, Jason
    Ludford, Kaysia
    Morris, Van K., II
    Wolff, Robert A.
    Wang, Xin Shelley
    Drusbosky, Leylah
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA3557 - LBA3557
  • [43] CAPECITABINE AND IRINOTECAN (CAPIRI) AS FIRST - LINE TREATMENT FOR PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Adda, B.
    Farida, S.
    ANNALS OF ONCOLOGY, 2009, 20 : 73 - 73
  • [44] Role of circulating tumor DNA (ctDNA) in assessing primary antieepidermal growth factor receptor (EGFR) resistance in untreated RAS/BRAF wild-type (WT) metastatic colorectal cancer (mCRC) patients (pts)
    Loh, J.
    Choo, J.
    Sooi, K.
    Low, P.
    Ang, C. S.
    Sundar, R.
    Walsh, R. J.
    Wijaya, S.
    Low, J. L.
    Hsing, S.
    Jain, S.
    Chee, C. E.
    ANNALS OF ONCOLOGY, 2023, 34 : S429 - S429
  • [45] Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with metastatic pancreatic cancer
    Pathak, Priyadarshini
    Li, Gerald
    Quintanilha, Julia
    Keller, Rachel Beth
    Pasquina, Lincoln
    Thierauf, Julia
    Graf, Ryon
    Parikh, Aparna Raj
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 621 - 621
  • [46] Circulating tumor DNA (ctDNA) to predict response to neoadjuvant chemotherapy (NAC) and prognosis in patients (pts) with early breast cancer (BC).
    McHayleh, Wassim
    Young, Ashley
    Burkovskaya, Valeria
    Galuia, Mariem
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Circulating tumor DNA (ctDNA) profile in patients (pts) with pancreatic cancer (PC): A multicenter experience and challenges for clinical application
    Ghiglione, L.
    Munoz i Carrillo, F. J.
    Esposito, F. M.
    Pesantez Coronel, D.
    Delcuratolo, M. D.
    Garcia-Carbonero, R.
    Fabregat-Franco, C.
    Alonso, G.
    Macarulla, T.
    Ceniceros Paredes, L.
    Ponz-Sarvise, M.
    Visa Turmo, L.
    Lopez Munoz, A. M.
    Pastor, B.
    Indacochea, A.
    Vicente Lazcano, M. P.
    Riva, F. N.
    Prat, A.
    Victoria, I.
    Sauri Nadal, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S905 - S905
  • [48] Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Keane, Fergus
    Saadat, Lily
    O'Connor, Catherine
    Chou, Joanne F.
    Brannon, Angela Rose
    Cowzer, Darren
    Crowley, Fionnuala
    Debnath, Neha
    Bowman, Anita
    Xu, Fei
    Park, Wungki
    Zervoudakis, Alice
    Balogun, Fiyinfolu
    Varghese, Anna M.
    Yu, Kenneth H.
    Kelsen, David Paul
    Capanu, Marinela
    Berger, Michael F.
    Wei, Alice Chia-Chi
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
    Yao, Jiannan
    Zang, Wanchun
    Ge, Yang
    Weygant, Nathaniel
    Yu, Pan
    Li, Lei
    Rao, Guanhua
    Jiang, Zhi
    Yan, Rui
    He, Linjia
    Yu, Yang
    Jin, Mulan
    Cheng, Gang
    An, Guangyu
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
  • [50] Detection and description of ERBB2 amplification using circulating cell free tumor DNA (ctDNA) genomic analysis in metastatic colorectal cancer (mCRC).
    Raghav, Kanwal Pratap Singh
    Loree, Jonathan M.
    Morris, Jeffrey
    Manuel, Shanequa
    Crosby, Shadarra
    Meric-Bernstam, Funda
    Menter, David
    Raymond, Victoria
    Lanman, Richard B.
    Talasaz, AmirAli
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345